Pfizer’s President and CEO, Albert Bourla, details the company’s income on The Claman Countdown.
Pharmaceutics The giant pfizer will pay nearly $ 60 million to resolve the accusations that a company she acquired has paid bribes so that doctors prescribe a specific drug against migraine to patients, thus fraud and others Federal health care programs.
The Ministry of Justice announced on Friday that Biohaven had paid inappropriate remuneration, in particular in the form of lecturer fees and meals in high -end restaurants, to health professionals to encourage them to prescribe drugs against migraine. NURTEC ODT Most often in violation of the anti-shower law.
The program took place from March 1, 2020 to September 30, 2022. Pfizer bought Biohaven in October 2022.
The Pfizer Inc. logo is visible on the laboratory blouse of an employee of the company research and development center in Cambridge, Massachusetts. Pfizer will pay nearly $ 60 million to settle the accusations that a company she acquired paid bribes. (Scott Eisen / Bloomberg via Getty Images / Getty Images)
The Paxlovid of Pfizer fails as a 15 -day treatment for the long covid, according to a study
Prosecutors said that some prescribers who participated in several speakers programs on the same subject have received no educational advantage by participating in repeated programs and that certain Biohaven speakers programs have been followed by people having no educational need to attend, such as spouses of speakers, family members or friends or colleagues from the medical office of the stakeholders.
Pfizer ended the NUTEC speaker programs after paying $ 11.5 billion to buy Biohaven.
“Patients deserve to know that their doctor prescribes medication on the basis of their medical judgment, not due to financial incentives for pharmaceutical companies,” said American Trini E. Ross prosecutor of the western New York district. “These regulations reflect our commitment to hold those who violate the laws as responsible, regardless of their status or prestige.”
A woman walks in front of Pfizer’s seat in New York. Pfizer will pay nearly $ 60 million to settle the accusations that a company she acquired paid bribes. (Eduardo Munozalvarez/ViewPress)
Pfizer is progressing the weight loss pill once daily in a current study
Pfizer did not recognize having committed a reprehensible act by accepting a regulation.
“We are happy to leave this inheritance behind us, so that we can continue to focus on the needs of patients,” said the Based in New York said the drug manufacturer in a statement.
NURTEC ODT, also known as Rimegeant, was approved for the treatment of acute migraine in February 2020 and its approval was extended to the prevention of episodic migraine in June 2021. The medication was promoted by the singer Lady Gaga In 2023, who declared in a publication on social networks that she had suffered from migraines since her childhood and said that she would have liked to find the medicine earlier.
The civil regulations resolved a trial brought in August 2021 before the Federal Court of Rochester, New York, by Patricia Frattasio, former specialist in neuroscience in Biohaven.
Lady Gaga participates in the photocall “Joker: Folie has two” during the 81st International Film Festival in Venice at the Palazzo del Casino on September 4 2024 in Venice, Italy. Gaga promoted the medication in 2023. (Stéphane Cardinale – Corbis / Corbis via Getty Images / Getty Images)
Get Fox Business on the move by clicking here
It will receive about $ 8.4 million in the regulation. About 41.8 million dollars will go to the federal government and $ 9.5 million to the Medicaid of States programs.
The False Claims Act allows whistleblowers to bring prosecution on behalf of the government and participate in recovery.
At the same time, the anti-pot-brown law prohibits offering or paying anything to encourage to recommend articles or services covered by Medicare, Medicaid, Tricare and other federal organizations. health care programs. The law aims to ensure that the judgment of medical care providers is not compromised by inappropriate financial incentives.
Reuters contributed to this report.
